Astragaloside IV regulates insulin resistance and inflammatory response of adipocytes via modulating miR-21/PTEN/PI3K/AKT signaling
Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammat...
Saved in:
Published in | Endocrine, metabolic & immune disorders drug targets |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
01.01.2023
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammatory response of adipocytes. The study also aimed to determine the downstream signaling pathways involved. Materials and methods The glucose consumption of adipocytes was assessed using a glucose assay kit. qRT-PCR, Western blot, and ELISA assays were used to measure mRNA and protein levels. The interaction between miR-21 and PTEN was assessed using a Dual-luciferase reporter assay. Results The results showed that AS-IV increased glucose consumption and the expression of GLUT-4 in adipocytes with insulin resistance in a concentration-dependent manner. However, AS-IV decreased the protein levels of TNF-α and IL-6 in these cells. Additionally, AS-IV up-regulated miR-21 expression in adipocytes with insulin resistance in a concentration-dependent manner. Furthermore, miR-21 overexpression increased glucose consumption and GLUT-4 expression but decreased TNF-α and IL-6 protein levels in adipocytes. Conversely, miR-21 inhibition attenuated the AS-IV-induced increase in glucose consumption and GLUT-4 expression and the decrease in TNF-α and IL-6 protein levels in adipocytes. MiR-21 also inversely regulated PTEN in adipocytes, and PTEN overexpression had effects similar to miR-21 inhibition in AS-IV-treated adipocytes. Finally, AS-IV up-regulated p-PI3K and p-AKT protein expression in adipocytes, which was attenuated by miR-21 inhibition. Conclusion The study concluded that AS-IV attenuated insulin resistance and the inflammatory response in adipocytes. The mechanistic studies indicated that AS-IV modulated the miR-21/PTEN/PI3K/AKT signaling in adipocytes to exert these effects. |
---|---|
AbstractList | Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammatory response of adipocytes. The study also aimed to determine the downstream signaling pathways involved. Materials and methods The glucose consumption of adipocytes was assessed using a glucose assay kit. qRT-PCR, Western blot, and ELISA assays were used to measure mRNA and protein levels. The interaction between miR-21 and PTEN was assessed using a Dual-luciferase reporter assay. Results The results showed that AS-IV increased glucose consumption and the expression of GLUT-4 in adipocytes with insulin resistance in a concentration-dependent manner. However, AS-IV decreased the protein levels of TNF-α and IL-6 in these cells. Additionally, AS-IV up-regulated miR-21 expression in adipocytes with insulin resistance in a concentration-dependent manner. Furthermore, miR-21 overexpression increased glucose consumption and GLUT-4 expression but decreased TNF-α and IL-6 protein levels in adipocytes. Conversely, miR-21 inhibition attenuated the AS-IV-induced increase in glucose consumption and GLUT-4 expression and the decrease in TNF-α and IL-6 protein levels in adipocytes. MiR-21 also inversely regulated PTEN in adipocytes, and PTEN overexpression had effects similar to miR-21 inhibition in AS-IV-treated adipocytes. Finally, AS-IV up-regulated p-PI3K and p-AKT protein expression in adipocytes, which was attenuated by miR-21 inhibition. Conclusion The study concluded that AS-IV attenuated insulin resistance and the inflammatory response in adipocytes. The mechanistic studies indicated that AS-IV modulated the miR-21/PTEN/PI3K/AKT signaling in adipocytes to exert these effects. |
Author | Yin, Taoqing Xu, Shuai Guo, Xuxi Zhang, Yue Ye, Renqun Chen, Dongni |
Author_xml | – sequence: 1 givenname: Xuxi surname: Guo fullname: Guo, Xuxi organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China – sequence: 2 givenname: Taoqing surname: Yin fullname: Yin, Taoqing organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China – sequence: 3 givenname: Dongni surname: Chen fullname: Chen, Dongni organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China – sequence: 4 givenname: Shuai surname: Xu fullname: Xu, Shuai organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China – sequence: 5 givenname: Renqun surname: Ye fullname: Ye, Renqun organization: Shenzhen Bao'an Traditional Chinese Medicine Hospital Department of Endocrinology Shenzhen China – sequence: 6 givenname: Yue surname: Zhang fullname: Zhang, Yue organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37366351$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kNFKwzAYhYMobs69gsQHqE3yt016OcacY0OHTG_H3yQtgTYtTSfs2he3Q706cA7ng3PuyLVvvSXkkbMnwWUScyV5CgwEZFkmgGVC8jFg7IpMheAiAiVhQuYhuIKlACoHkLdkAnIsQMqn5HsRhh4rrNvgjKWbT9rb6lTjYAN1Ppxq50cnuDCg15aiN6Nd1tg0OLT9-ZJ1rQ-WtiVF47pWny_VL4e0ac0F5HxFG_ceCR7vD6vXeL-BbbzYHmhwlceRX92TmxLrYOd_OiMfz6vD8iXava03y8UuKhIphkhrJbFMBC8yHBdLIxSDMtFK51KCKmWRW840gzxB5AY1z23KMqUSmZXWGjEjD7_c7lQ01hy73jXYn4__b4gfvklljw |
CitedBy_id | crossref_primary_10_1016_j_heliyon_2024_e35747 crossref_primary_10_3390_metabo14020122 crossref_primary_10_1016_j_prp_2024_155091 crossref_primary_10_3892_br_2024_1918 crossref_primary_10_3390_molecules28166118 crossref_primary_10_1016_j_brainres_2025_149451 |
ContentType | Journal Article |
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
DBID | NPM |
DOI | 10.2174/1871530323666230627121700 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 2212-3873 |
ExternalDocumentID | 37366351 |
Genre | Journal Article |
GroupedDBID | ABJNI ALMA_UNASSIGNED_HOLDINGS NPM |
ID | FETCH-LOGICAL-b472t-cc87af421b6a3237d2803f4c8c97738f7b9e10c0394aa1dac19e50688476feed2 |
IngestDate | Thu Jan 02 22:52:21 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | T2DM AS-IV miR-21 inflammation adipocytes insulin resistance |
Language | English |
License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b472t-cc87af421b6a3237d2803f4c8c97738f7b9e10c0394aa1dac19e50688476feed2 |
PMID | 37366351 |
ParticipantIDs | pubmed_primary_37366351 |
PublicationCentury | 2000 |
PublicationDate | 2023-01-01 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United Arab Emirates |
PublicationPlace_xml | – name: United Arab Emirates |
PublicationTitle | Endocrine, metabolic & immune disorders drug targets |
PublicationTitleAlternate | Endocr Metab Immune Disord Drug Targets |
PublicationYear | 2023 |
SSID | ssib053389337 |
Score | 2.353132 |
Snippet | Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be... |
SourceID | pubmed |
SourceType | Index Database |
Title | Astragaloside IV regulates insulin resistance and inflammatory response of adipocytes via modulating miR-21/PTEN/PI3K/AKT signaling |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37366351 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lRap6QSDeLy0SN8sk3rW99rFChZaKCiEX5Vat17vBErFDiBHttb-Ef8rMrl9EVDwuTmTHz_kyO994dj5CXmgVxiZmxk-FVD6Mx8qXwYz7JtIJ11FeCKve8O40PjoL386j-WTyY1S11Gzyl-ryt_NK_seqsA7sirNk_8Gy_UFhBXwH-8ISLAzLv7LxAeYpwMXXqLnpAZFbO2V5W2TlasyBTWOE2M0LgLMCBJbu1fra1cdqVwtQrmp1gbt-KyUK5Fhdr2rhLcsPPkN_9z47PMWPY36CXRhOMg-LP-TnbvDr8vtVUat16TKlS70BlGEjbYRYiZNRNL4Ush0_v3rFull4rhi9j-3fNDZ7O2--l71Lco0OMll_6U5mKxJal1lXi6r_7byxCd1PjSzHGQ3GRxkNbT0fY9hJMXEaJ9s-HjkUphuA6UUw_jIOBAx5FBMBw2aD433AXKulNT4XHGOr4M9bt9pvd5t2yA4QEVRWHdJBECpDuMfFHnneXtj02svaJ3vdobYYjI1kslvkZktB6IHD020y0dUdcvULlujxR9pjibZYogOWKGCJjrFEOyzR2tABSxSwRAcsUYelKSJpijiaAopoj6K75Oz1YfbqyG8FOvw8FGzjK5UIaUIW5LGEOxYFSp2ZUCUKWAVPjMhTHczUjKehlEEhVZDqCFWOQhEbCM7YPbJb1ZV-QKhQSKbzPBK5DE0gElOERVIYkapAFdHsIbnvntn5ynVhOe-e5qNrtzwm-wO8npAbBv72-inEkJv8mbXjT3XTcJI |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Astragaloside+IV+regulates+insulin+resistance+and+inflammatory+response+of+adipocytes+via+modulating+miR-21%2FPTEN%2FPI3K%2FAKT+signaling&rft.jtitle=Endocrine%2C+metabolic+%26+immune+disorders+drug+targets&rft.au=Guo%2C+Xuxi&rft.au=Yin%2C+Taoqing&rft.au=Chen%2C+Dongni&rft.au=Xu%2C+Shuai&rft.date=2023-01-01&rft.eissn=2212-3873&rft_id=info:doi/10.2174%2F1871530323666230627121700&rft_id=info%3Apmid%2F37366351&rft_id=info%3Apmid%2F37366351&rft.externalDocID=37366351 |